Researchers from IIT Roorkee used an existing anti-viral drug Piperazine for the cure of chikungunya.
Currently, there is no cure for the disease.
Piperazine is used for the treatment of worm infections.
The anti-viral activity of Piperazine molecule inhibits virus replication.
The drug binds to the target, the protein's interaction with the enveloped protein of virus is inhibited and hence the virus release from infected cell is affected.